Enterbiotix

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

Vedanta Biosciences

This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

BEO Therapeutics

This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.